Open Access Open Access  Restricted Access Subscription or Fee Access

Web Based Resource for the Study of Heart Disease-Treatment

P. Senthilraja, P. Deepika, Dr.B. G. Geetha

Abstract


The Machine Learning (ML) field has gained its momentum in almost any domain of research and just recently has become a reliable tool in the medical domain. The empirical domain of automatic learning is used in tasks such as medical decision support, protein-protein interaction, extraction of medical knowledge, and for overall patient management care. ML is envisioned as a tool by which computer-based systems can be integrated in the healthcare field in order to get a better, more efficient medical care. This paper describes a ML-based methodology for building an application that is capable of identifying and disseminating healthcare information. It identifies semantic relations that exist between diseases and treatments. This paper tells a platform to enhance effectiveness and efficiency of home monitoring using data mining for early detection of any worsening in patient’s condition. These worsening could require more complex and expensive care if not recognized. Disease management programs, which use no advanced information and computer technology, are as effective as telemedicine but more efficient because less costly. The platform improved home monitoring by adding data mining functionalities. This was important in order to improve home monitoring effectiveness and efficiency, especially benchmarking telemedicine to other disease management programs, and not only to ambulatory follow-up.

Keywords


Data Mining (DM), Heart Failure (HF), Heart Rate Variability (HRV), Home Monitoring (HM).

Full Text:

PDF

References


S. Koch, ―Home telehealth—Current state and future trends,‖ Int. J. Med.Inform., vol. 75, no. 8, pp. 565–576, 2006.

C. S. Pattichis, C. N. Schizas, M. S. Pattichis, E. Micheli-Tzanakou, E. C. Kyriakou, and D. I. Fotiadis, ―Introduction to the special section on computational intelligence in medical systems,‖ IEEE Trans. Inform.Technol. Biomed., vol. 13, no. 5, pp. 667–672, Sep. 2009.

S. G. Mougiakakou, I. K. Valavanis, N. A. Mouravliansky, A. Nikita, and K. S. Nikita, ―DIAGNOSIS: A telematics-enabled system for medical image archiving, management, and diagnosis assistance,‖ IEEE Trans. Instrum. Meas., vol. 58, no. 7, pp. 2113–2120, Jul. 2009.

P. A. Bath, ―Data mining in health and medical information,‖ Annu. Rev.Inform. Sci. Technol., vol. 38, pp. 331–369, 2004.

R. Gaikwad and J.Warren, ―The role of home-based information and communications technology interventions in chronic disease management: A systematic literature review,‖ Health Inform. J., vol. 15, no. 2, pp. 122– 146, 2009.

A. Martinez, E. Everss, J. L. Rojo-Alvarez, D. P. Figal, and A. Garcia- Alberola, ―A systematic review of the literature on home monitoring for patients with heart failure,‖ J. Telemed. Telecare, vol. 12, no. 5, pp. 234–241, 2006.

J. Gonseth, P. Guallar-Castillon, J. R. Banegas, and F. Rodriguez-Artalejo, ―The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: A systematic review and meta-analysis of published reports,‖ Eur. Heart J., vol. 25, no. 18, pp. 1570–1595, 2004.

M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis,T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, L. W. Stevenson, C. W. Yancy, S. A. Hunt, M. H. Chin, H. F. W. Comm, and W. C. Members, ―2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines,‖ Circulation, vol. 119, no. 14, pp. 1977–2016, 2009.

G. Pare, M. Jaana, and C. Sicotte, ―Systematic review of home telemonitoring for chronic diseases: The evidence base,‖ J. Amer. Med. Inform.Assoc., vol. 14, no. 3, pp. 269–277, 2007.

L. Pecchia, U. Bracale, and M. Bracale, ―Health technology assessment of home monitoring for the continuity of care of patient suffering from congestive heart failure,‖ in Proc.Med. Phys. Biomed. Eng.World. Congr., Munich, Germany, 2009, pp. 184–187.

L. Liao, J. G. Jollis, K. J. Anstrom, D. J. Whellan, D. W. Kitzman, G. P.Aurigemma, D. B.Mark, K. A. Schulman, and J. S. Gottdiener, ―Costs for heart failure with normal vs reduced ejection fraction,‖ Arch. Int. Med., vol. 166, no. 1, pp. 112–118, 2006.

D. Lloyd-Jones, R. J. Adams, T. M. Brown, M. Carnethon, S. Dai, G. De Simone, T. B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenland, N. Haase, S. Hailpern, P. M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M. M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V. Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, T. Thom, S. Wasserthiel- Smoller, N. D. Wong, and J. Wylie-Rosett, ―Heart disease and stroke statistics—2010 Update. A report from the American Heart Association,‖ Circulation, vol. 121, no. 12, pp. e1–e260, 2009.

M. R. Cowie, A. Mosterd, D. A.Wood, J.W. Deckers, P. A. PooleWilson, G. C. Sutton, and D. E. Grobbee, ―The epidemiology of heart failure,‖ Eur. Heart J., vol. 18, no. 2, pp. 208–225, 1997.

M. Malik, J. T. Bigger, A. J. Camm, R. E. Kleiger, A.Malliani, A. J. Moss, and P. J. Schwartz, ―Heart rate variability: Standards of measurement, physiological interpretation, and clinical use,‖ Eur. Heart J., vol. 17, no. 3, pp. 354–381, 1996.

P. Melillo, L. Pecchia, and M. Bracale, ―Interactive voice response system for home telemonitoring of heart failure patients,‖ in Proc. Med.Phy. Biomed. Eng. World Congr., Munich, Germany, 2009, pp. 153– 156.

A. L. Goldberger, L. A. N. Amaral, L. Glass, J. M. Hausdorff, P. C. Ivanov, R. G. Mark, J. E. Mietus, G. B. Moody, C.-K. Peng, and H. E. Stanley, ―Physiobank, physiotoolkit, and physionet: Components of a new research resource for complex physiologic signals,‖ Circulation, vol. 101, no. 23, pp. e215–e220, 2000.[17] Lombardi F, Torzillo D, Sandrone G et al. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability. Am J Cardiol pp.1028–34,1992.

Fei L, Malik M. Short- and long-term assessment of heart rate variability for post infarction risk stratification. In: Malik M, Camm AJ, eds. Heart rate variability. Armonk: Futura, pp.341–346,1995.

Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol, pp.729–736, 1993.

Camm AJ, Fei L. Risk stratification following myocardial infarction: Heart rate variability and other risk factors. In: Malik M, Camm AJ, eds. Heart rate variability. Armonk: Futura, pp.369–392, 1995.

Vybiral T,Glaser DH, Morris G et al. Effects of low dose scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol, pp.1320–1326, 1993.

LaRovere MT, Mortara A, Pantaneleo P, Maestri R, Cobelli F, Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure.Circulation, pp.838–843, 1994.

Louis A, Turner T, Gretton M, Baksh A, Cleland J. A systematicreview of telemonitoring for the management of heart failure. Eur J Heart Fail, pp.83–90, 2003.

Vincent JA, Cavitt DL, Carpawich PP. Diagnostic and cost effectiveness of telemonitoring the pediatric pacemaker patients. Pediatr Cardiol, pp.86 –90, 1997.

Chase H.P, Pearson J.A, Wightman C, Roberts M.D, Oderberg D, Garg SK. Modem transmission of glucose values reduces the cost and need for clinic visits. Diabetes Care, pp.1475–1479, 2003.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.